Literature DB >> 30099742

Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement.

Julphat Intarasupht1, Anchisa Kanchanomai1, Wuttirak Leelasattakul1, Thoranis Chantrarat1, Artit Nakakes1, Waraporn Tiyanon1.   

Abstract

BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous drug reaction that can affect multiple internal organ systems. Cardiac involvement in DRESS syndrome (CiDs) is uncommon but can be life-threatening.
OBJECTIVE: To determine the prevalence, risk factors, and mortality outcome of CiDs.
MATERIAL AND METHODS: Forty-one patients who were diagnosed with probable and definite DRESS syndrome according to the RegiSCAR criteria were recruited. Cardiac involvement was evaluated by two independent cardiologists.
RESULTS: The cardiac involvement was found in 8/41 (19.5%) patients. Specifically, myocardial involvement was found in five patients, while three patients had pericardial involvement. The majority of culprit drugs were antibiotics followed by anti-epileptic medications. The hemoglobin and albumin levels were significantly lower in the patients with CiDs when compared to the patients without CiDs (P-value = 0.005 for both factors). The mortality rate at 30 and 90 days was significantly higher among CiDs patients, that is, 3/8 (37.5%) versus 2/28 (6.1%); P-value = 0.02 and 4/8 (50.0%) versus 2/33 (6.1%); P-value = 0.002 respectively.
CONCLUSION: Our study showed the prevalence of CiDs was as high as 19.5% with high mortality rate. We suggest a thorough cardiac evaluation in all DRESS patients with RegiSCAR score ≥4. The patients with CiDs had significantly lower hemoglobin and albumin levels, which might imply poor health condition, when compared to those without CiDs.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30099742     DOI: 10.1111/ijd.14174

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  DRESS characteristics according to the causative medication.

Authors:  A Chaabane; H Ben Romdhane; N Ben Fadhel; N Ben Fredj; H Ammar; N Boughattas; Z Chadly; K Aouam
Journal:  Eur J Clin Pharmacol       Date:  2022-06-20       Impact factor: 3.064

Review 2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

Review 3.  "Heart in DRESS": Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review.

Authors:  Milan Radovanovic; Djordje Jevtic; Andrew D Calvin; Marija Petrovic; Margaret Paulson; Libardo Rueda Prada; Lawrence Sprecher; Ivana Savic; Igor Dumic
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

4.  Management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a female Indonesian with pulmonary tuberculosis: A rare case report.

Authors:  Aghnia Permatasari; Gatot Soegiarto
Journal:  Ann Med Surg (Lond)       Date:  2022-08-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.